Robert J. Lynch
University of Wisconsin–Green Bay(US)
Publications by Year
Research Areas
Platelet Disorders and Treatments, Cell Adhesion Molecules Research, Monoclonal and Polyclonal Antibodies Research, Antiplatelet Therapy and Cardiovascular Diseases, HER2/EGFR in Cancer Research
Most-Cited Works
- → Non-peptide fibrinogen receptor antagonists. 1. Discovery and design of exosite inhibitors(1992)295 cited
- → Non-Peptide Fibrinogen Receptor Antagonists. 2. Optimization of a Tyrosine Template as a Mimic for Arg-Gly-Asp(1994)178 cited
- → Nonpeptide glycoprotein IIb/IIIa inhibitors: Substituted quinazolinediones and quinazolinones as potent fibrinogen receptor antagonists(1998)114 cited
- → Evidence for a Brain Site of Melatonin Action in the White-Footed Mouse, <i>Peromyscus leucopus</i>(1982)98 cited
- → Nonpeptide glycoprotein IIb/IIIa inhibitors. 5. Antithrombotic effects of MK-0383.(1995)67 cited
- → Non-Peptide Glycoprotein IIb/IIIa Antagonists. 11. Design and in Vivo Evaluation of 3,4-Dihydro-1(1H)-isoquinolinone-Based Antagonists and Ethyl Ester Prodrugs(1996)64 cited
- → Non-Peptide Glycoprotein IIb/IIIa Inhibitors. 17. Design and Synthesis of Orally Active, Long-Acting Non-Peptide Fibrinogen Receptor Antagonists(1997)56 cited
- → Synthesis and use of 3-amino-4-phenyl-2-piperidones and 4-amino-2-benzazepin-3-ones as conformationally restricted phenylalanine isosteres in renin inhibitors(1992)55 cited
- → Design and synthesis of P2-P1'-linked macrocyclic human renin inhibitors(1991)55 cited
- → Non-Peptide GPIIb/IIIa Inhibitors. 20. Centrally Constrained Thienothiophene α-Sulfonamides Are Potent, Long Acting in Vivo Inhibitors of Platelet Aggregation(1999)50 cited